SOX9 and neoplasm: Notably, compared to H1299‐shSOX9 cells expressing WT SOX9, cells expressing the ubiquitination‐deficient SOX9 mutants (4KR or K249R) showed increased tumor growth in xenograft model (Figure 6L,M and Figure S4G, Supporting Information).